Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Sep 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences:
Read more at globenewswire.com
